Monday, March 30, 2026

Can a common heart drug help people with acute heart failure breathe easier?

Plain Language Summary
What this means for you:
A heart drug may ease breathing by helping the heart pump better and the body remove fluid.

Imagine your heart suddenly struggling to pump blood. Fluid backs up into your lungs, making every breath a fight. That's acute heart failure. Doctors often use a drug called nitroglycerin in these emergencies. It works by relaxing and widening blood vessels, which takes some pressure off the tired heart. This study wanted to understand exactly how that drug helps in the crucial early hours of treatment. The researchers had a specific idea: that nitroglycerin would do two key things. First, increase the amount of blood the heart pumps out with each beat (called stroke volume). Second, help the kidneys make more urine, which is the body's way of flushing out the dangerous extra fluid causing congestion and shortness of breath. By closely watching 21 patients, the team measured heart function, blood volume, and fluid levels during nitroglycerin treatment. Their main goal wasn't just to see if the drug worked, but to identify the specific types of patients who respond best to it. This knowledge could help doctors use this common medication more precisely, targeting it to the people most likely to get rapid relief from that terrifying feeling of drowning in their own fluid.

What this means for you:
A heart drug may ease breathing by helping the heart pump better and the body remove fluid.
Read the Full Clinical Summary →
View Original Abstract ↓
Status: COMPLETED | Phase: PHASE4 Condition(s): Acute Heart Failure (AHF) Intervention(s): Nitroglycerin (NTG) (DRUG) This study aims to understand how nitroglycerin affects patients with acute heart failure, a condition where the heart struggles to pump blood effectively, leading to fluid buildup and breathing difficulties. Nitroglycerin relaxes blood vessels to ease the heart's workload and may help reduce fluid buildup. The investigators hypothesize that nitroglycerin can increase blood flow from the heart and promote urine production, which may reduce congestion in AHF patients. By studying heart function, blood volume, and fluid levels during treatment, the goal is to identify which patients may benefit most from nitroglycerin therapy. Primary Outcome(s): Stroke volume Enrollment: 21 (ACTUAL) Lead Sponsor: Copenhagen University Hospital, Hvidovre Start: 2025-02-01 | Primary Completion: 2025-11-30